Roche Holding AG
SIX:ROG
Roche Holding AG
Change in Working Capital
Roche Holding AG
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Change in Working Capital
-CHf6.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
Novartis AG
SIX:NOVN
|
Change in Working Capital
-$5.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Change in Working Capital
$1.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Change in Working Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Change in Working Capital?
Change in Working Capital
-6.5B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Change in Working Capital amounts to -6.5B CHF.
What is Roche Holding AG's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-3%
Over the last year, the Change in Working Capital growth was 21%. The average annual Change in Working Capital growth rates for Roche Holding AG have been 4% over the past three years , -6% over the past five years , and -3% over the past ten years .